496 related articles for article (PubMed ID: 16611855)
1. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
Rockwell CE; Snider NT; Thompson JT; Vanden Heuvel JP; Kaminski NE
Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
[TBL] [Abstract][Full Text] [Related]
2. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.
Kaplan BL; Ouyang Y; Rockwell CE; Rao GK; Kaminski NE
J Leukoc Biol; 2005 Jun; 77(6):966-74. PubMed ID: 15774549
[TBL] [Abstract][Full Text] [Related]
3. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.
Raman P; Kaplan BL; Kaminski NE
J Pharmacol Exp Ther; 2012 Sep; 342(3):816-26. PubMed ID: 22700433
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.
Raman P; Kaplan BL; Thompson JT; Vanden Heuvel JP; Kaminski NE
Mol Pharmacol; 2011 Jul; 80(1):201-9. PubMed ID: 21511917
[TBL] [Abstract][Full Text] [Related]
5. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Rockwell CE; Kaminski NE
J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
[TBL] [Abstract][Full Text] [Related]
6. A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells.
Rockwell CE; Raman P; Kaplan BL; Kaminski NE
Biochem Pharmacol; 2008 Aug; 76(3):353-61. PubMed ID: 18571623
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.
Du H; Chen X; Zhang J; Chen C
Br J Pharmacol; 2011 Aug; 163(7):1533-49. PubMed ID: 21501147
[TBL] [Abstract][Full Text] [Related]
8. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.
Ouyang Y; Hwang SG; Han SH; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):676-83. PubMed ID: 9547358
[TBL] [Abstract][Full Text] [Related]
9. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
[TBL] [Abstract][Full Text] [Related]
10. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
11. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.
Bouaboula M; Hilairet S; Marchand J; Fajas L; Le Fur G; Casellas P
Eur J Pharmacol; 2005 Jul; 517(3):174-81. PubMed ID: 15987634
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
Chung SW; Kang BY; Kim TS
Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
[TBL] [Abstract][Full Text] [Related]
13. Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide.
Spelman K; Iiams-Hauser K; Cech NB; Taylor EW; Smirnoff N; Wenner CA
Int Immunopharmacol; 2009 Oct; 9(11):1260-4. PubMed ID: 19712756
[TBL] [Abstract][Full Text] [Related]
14. Negative Regulation of Leptin-induced Reactive Oxygen Species (ROS) Formation by Cannabinoid CB1 Receptor Activation in Hypothalamic Neurons.
Palomba L; Silvestri C; Imperatore R; Morello G; Piscitelli F; Martella A; Cristino L; Di Marzo V
J Biol Chem; 2015 May; 290(22):13669-77. PubMed ID: 25869131
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species.
Siegmund SV; Qian T; de Minicis S; Harvey-White J; Kunos G; Vinod KY; Hungund B; Schwabe RF
FASEB J; 2007 Sep; 21(11):2798-806. PubMed ID: 17440119
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
17. CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition.
Panikashvili D; Mechoulam R; Beni SM; Alexandrovich A; Shohami E
J Cereb Blood Flow Metab; 2005 Apr; 25(4):477-84. PubMed ID: 15729296
[TBL] [Abstract][Full Text] [Related]
18. 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells.
Zhao Q; He Z; Chen N; Cho YY; Zhu F; Lu C; Ma WY; Bode AM; Dong Z
J Biol Chem; 2005 Jul; 280(29):26735-42. PubMed ID: 15886210
[TBL] [Abstract][Full Text] [Related]
19. N-Oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte.
Wang S; Xu Q; Shu G; Wang L; Gao P; Xi Q; Zhang Y; Jiang Q; Zhu X
Biochem Biophys Res Commun; 2015 Oct; 466(3):438-43. PubMed ID: 26365347
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
